Apple (AAPL, $178.97) to buy Tueo Health to boost its heath features across products
In line with its strategy to buy several small acquisitions of start-ups, Apple’s latest haul is Tueo Health, a small start-up committed to developing a system of helping parents monitor asthma symptoms in sleeping children. It is likely that in late 2018 Apple concluded its acquisition of the said company for an undisclosed investment. In 2017, the start-up raised a modest $1.1 million in funding.
Tueo Health’s mobile app works with commercial breathing sensors to help manage asthma symptoms in children while they are sleeping. The app would send signals to their parents if their child’s breathing has changed during the night.
Over the last few years, Apple has been adding health technologies to its portfolio. The latest version of the Apple Watch can perform an electrocardiogram and detect when the user falls.
It is also anticipated that as part of its iOS update, the Health app for iPhones will be able to track menstrual cycles. The company is scheduled to announce its new operating system’s features at the annual developer’s conference in June.
So far, Apple has made only two other health acquisitions. In 2016 it bought the start-up Gliimpse that is capable of aggregating medical records and Beddit in 2017 which makes sleep sensors.
AAPL sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for AAPL moved above the 200-day moving average on September 15, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 12, 2025. You may want to consider a long position or call options on AAPL as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AAPL advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 298 cases where AAPL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for AAPL moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Moving Average Convergence Divergence Histogram (MACD) for AAPL turned negative on September 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AAPL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AAPL broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. AAPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AAPL's P/B Ratio (53.763) is very high in comparison to the industry average of (4.178). P/E Ratio (36.266) is within average values for comparable stocks, (32.587). Projected Growth (PEG Ratio) (2.296) is also within normal values, averaging (2.001). Dividend Yield (0.004) settles around the average of (0.027) among similar stocks. P/S Ratio (8.834) is also within normal values, averaging (252.905).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of mobile communication, media devices, personal computers, and portable digital music players
Industry ComputerPeripherals
Advertisement